Effectiveness comparison of palbociclib, ribociclib and abemaciclib in patients with HR+/HER2- aBC: Updated results from the real-world, Italian study PALMARES-2.Claudio Vernieri, Giuseppe Curigliano, Francesco Pantano et al.|Journal of Clinical Oncology|2025Cited by 1